Yelloji-Rao K. Mirajkar,Jairajh Mattai,Michael Prencipe
申请号：
US13260822
公开号：
US20120039822A1
申请日:
2009.04.01
申请国别(地区):
US
年份:
2012
代理人:
摘要：
An oral composition comprising an orally acceptable vehicle for such composition, an effective therapeutic amount of an antibacterial compound comprising a halogenated diphenyl ether, an effective therapeutic amount of an anti-hypersensitivity agent comprising a potassium salt, and a solubilizing agent for the antibacterial compound, the solubilizing agent comprising, in combination, sodium lauryl sulfate and a cyclodextrin.
